source
- GSK gains another cancer drug approval and unveils promising chemo data as it prepares for lung cancer approvalGSK received regulatory approval this week for one of its cancer medicines in an additional tumor indication, expanding the portfolio that has grown since the company re-entered oncology a decade a…
- Incyte reports lasting tumor responses in pancreatic cancer patients using targeted drug plus chemotherapyIncyte announced at the European Society for Medical Oncology meeting that its targeted therapy, when combined with standard chemotherapy, produced durable tumor responses in a subset of pancreatic…